For PFS, high expression of ZC3H13 was also associated with favorable prognosis in KIRC, kidney renal papillary cell carcinoma (KIRP) and prostate adenocarcinoma (PRAD) and poor prognosis in CESC (Supplementary Figure 3). Here, ZC3H13 is linked to prostate adenocarcinoma.